127 related articles for article (PubMed ID: 21308986)
1. An in vitro study of blood compatibility of vascular grafts made of bacterial cellulose in comparison with conventionally-used graft materials.
Fink H; Hong J; Drotz K; Risberg B; Sanchez J; Sellborn A
J Biomed Mater Res A; 2011 Apr; 97(1):52-8. PubMed ID: 21308986
[TBL] [Abstract][Full Text] [Related]
2. Real-time measurements of coagulation on bacterial cellulose and conventional vascular graft materials.
Fink H; Faxälv L; Molnár GF; Drotz K; Risberg B; Lindahl TL; Sellborn A
Acta Biomater; 2010 Mar; 6(3):1125-30. PubMed ID: 19800035
[TBL] [Abstract][Full Text] [Related]
3. Improved blood compatibility of a stent graft by combining heparin coating and abciximab.
Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
Thromb Res; 2005; 115(3):245-53. PubMed ID: 15617748
[TBL] [Abstract][Full Text] [Related]
4. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
[TBL] [Abstract][Full Text] [Related]
5. Hemocompatibility study of a bacterial cellulose/polyvinyl alcohol nanocomposite.
Leitão AF; Gupta S; Silva JP; Reviakine I; Gama M
Colloids Surf B Biointerfaces; 2013 Nov; 111():493-502. PubMed ID: 23880088
[TBL] [Abstract][Full Text] [Related]
6. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
[TBL] [Abstract][Full Text] [Related]
7. In vitro hemo- and cytocompatibility of bacterial nanocelluose small diameter vascular grafts: Impact of fabrication and surface characteristics.
Wacker M; Kießwetter V; Slottosch I; Awad G; Paunel-Görgülü A; Varghese S; Klopfleisch M; Kupitz D; Klemm D; Nietzsche S; Petzold-Welcke K; Kramer F; Wippermann J; Veluswamy P; Scherner M
PLoS One; 2020; 15(6):e0235168. PubMed ID: 32579611
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
Moll S; De Moerloose P; Reber G; Schifferli J; Leski M
Int J Artif Organs; 1990 May; 13(5):273-9. PubMed ID: 2142140
[TBL] [Abstract][Full Text] [Related]
9. In vitro haemocompatibility of a novel bioprosthetic total artificial heart.
Jansen P; van Oeveren W; Capel A; Carpentier A
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e166-72. PubMed ID: 22491668
[TBL] [Abstract][Full Text] [Related]
10. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and complement activation.
Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
Biomaterials; 2001 Feb; 22(4):349-55. PubMed ID: 11205438
[TBL] [Abstract][Full Text] [Related]
12. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
14. The effect of heparin vs. citrate on the interaction of platelets with vascular graft materials.
Kottke-Marchant K; Anderson JM; Rabinovitch A; Huskey RA; Herzig R
Thromb Haemost; 1985 Dec; 54(4):842-8. PubMed ID: 2935968
[TBL] [Abstract][Full Text] [Related]
15. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface.
Larsson R; Elgue G; Larsson A; Ekdahl KN; Nilsson UR; Nilsson B
Immunopharmacology; 1997 Dec; 38(1-2):119-27. PubMed ID: 9476123
[TBL] [Abstract][Full Text] [Related]
17. Hirudin versus heparin for use in whole blood in vitro biocompatibility models.
Bexborn F; Engberg AE; Sandholm K; Mollnes TE; Hong J; Nilsson Ekdahl K
J Biomed Mater Res A; 2009 Jun; 89(4):951-9. PubMed ID: 18470919
[TBL] [Abstract][Full Text] [Related]
18. The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation.
Gabutti L; Ferrari N; Mombelli G; Keller F; Marone C
J Nephrol; 2004; 17(6):819-25. PubMed ID: 15593057
[TBL] [Abstract][Full Text] [Related]
19. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response.
Lamba NM; Courtney JM; Gaylor JD; Lowe GD
Biomaterials; 2000 Jan; 21(1):89-96. PubMed ID: 10619682
[TBL] [Abstract][Full Text] [Related]
20. A protamine filter for extracorporeal heparin removal. Development, testing, blood compatibility evaluation, and future direction.
Byun Y; Yun JH; Han IS; Fu Y; Shanberge JN; Yang VC
ASAIO J; 1995; 41(3):M301-5. PubMed ID: 8573812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
